Overview

Sobhan Oncology is the first of its kind in Iran due to its complex manufacturing technology and heavy capital investments involved in creation of such a plant. This enables Sobhan Oncology Company to establish itself as the prime provider and producer of anti-cancer medicines in Iran along with the Region. This plant is using all the latest technology available in terms of design and machinery. The plant was designed according to the latest cGMP, EMEA and WHO guidelines and directives. Sobhan Oncology Co. is the first and most leading manufacturer of Anti-Cancer medicines in IRAN, designed by Iranian scientists and technicians according to latest cGMP, EMEA and WHO guidelines and directives under the supervision of M+W company from Germany. Sobhan Oncology is member of Barekat Pharmaceutical Holding Group and Alborz Investment Co. in IRAN. The Company is in partnership with Roche (Switzerland), Sanofi (France), Stragen (Switzerland), Biosyn (Germany), Ebewe (Austria), Gedeon Richter (Hungary), Cipla (India), Nippon Kayaku (Japan) and etc. Managing Director: Sobhan Oncology pharmaceutical company, as a pioneer and innovative in the Iranian pharmaceutical industry along with its beneficiaries such as: Physicians, Pharmacist, nurses, employees, share holders and its commercial partners from around the world has vowed to fulfill the patients need and to take care of their hopes to be met in order to improve their health, protect their life, offer them some innovative solutions, provide easy and quick access to their medicines. We live to “ keeping hope alive”